LMAT vs TFX · P/E 35, rev $136.9M vs P/E 2083, rev $1.12B
LeMaitre Vascular Inc (LMAT) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported LMAT revenue for 2026-06-30 was $136.9M. Net income was $32.7M. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
LMAT currently screens at market cap $2.16B and trailing P/E 34.8. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the LMAT and TFX stock pages for the full models.
Not investment advice.